Related Experiment Video
Updated: Apr 5, 2026

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo
Enrico Caserta1, Onur Egriboz1, Hui Wang1
1Solid Tumor Biology Program, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA; Department of Molecular Genetics, College of Arts and Sciences, The Ohio State University, Columbus, Ohio 43210, USA; Department of Molecular Virology, Immunology, and Medical Genetics, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA;
Abstract:
Inactivation of phosphatase and tensin homology deleted on chromosome 10 (PTEN) is linked to increased PI3K-AKT signaling, enhanced organismal growth, and cancer development. Here we generated and analyzed Pten knock-in mice harboring a C2 domain missense mutation at phenylalanine 341 (Pten(FV)), found in human cancer. Despite having reduced levels of PTEN protein, homozygous Pten(FV/FV) embryos have intact AKT signaling, develop normally, and are carried to term. Heterozygous Pten(FV/+) mice develop carcinoma in the thymus, stomach, adrenal medulla, and mammary gland but not in other organs typically sensitive to Pten deficiency, including the thyroid, prostate, and uterus. Progression to carcinoma in sensitive organs ensues in the absence of overt AKT activation. Carcinoma in the uterus, a cancer-resistant organ, requires a second clonal event associated with the spontaneous activation of AKT and downstream signaling. In summary, this PTEN noncatalytic missense mutation exposes a core tumor suppressor function distinct from inhibition of canonical AKT signaling that predisposes to organ-selective cancer development in vivo.
Insights
A phosphatase and tensin homology deleted on chromosome 10 (PTEN) mutation, Pten(FV), impacts tumor suppression independently of AKT signaling. This study reveals organ-selective cancer development linked to this PTEN mutation in mice.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Inactivation of phosphatase and tensin homology deleted on chromosome 10 (PTEN) is a known driver of cancer via increased PI3K-AKT signaling.
- PTEN's tumor suppressor role is critical in regulating cell growth and preventing tumorigenesis.
Purpose of the Study:
- To investigate the in vivo tumor suppressor function of a PTEN C2 domain missense mutation (Pten(FV)), identified in human cancers.
- To determine if this mutation affects AKT signaling and leads to organ-selective cancer development.
Main Methods:
- Generation and analysis of Pten knock-in mice harboring the Pten(FV) mutation.
- Assessment of AKT signaling pathways in Pten(FV/FV) and Pten(FV/+) mice.
- Histopathological examination of various organs for carcinoma development.
Main Results:
- Homozygous Pten(FV/FV) embryos showed normal development despite reduced PTEN protein and intact AKT signaling.
- Heterozygous Pten(FV/+) mice developed carcinoma in specific organs (thymus, stomach, adrenal medulla, mammary gland) but not others.
- Tumor progression in sensitive organs occurred without overt AKT activation, while uterine cancer required secondary AKT activation.
Conclusions:
- The Pten(FV) mutation exhibits a tumor suppressor function independent of canonical AKT signaling inhibition.
- This PTEN mutation predisposes to organ-selective cancer development through mechanisms distinct from AKT pathway activation.
- Understanding this novel tumor suppressor function is crucial for targeted cancer therapies.
More Related Videos
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

